Growth Metrics

Nuwellis (NUWE) Leases (2019 - 2026)

Nuwellis posted quarterly Leases of $237000.0 for Q1 2026, down 48.14% year-on-year from $457000.0 in Q1 2025, and down 19.11% on a QoQ basis from $293000.0 in Q4 2025.

Nuwellis (NUWE) has 8 years of Leases data on file, last reported at $237000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Leases fell 48.14% year-over-year to $237000.0; the trailing twelve-month figure through Mar 2026 stood at $237000.0 (down 48.14% YoY), and the FY2025 full-year result was $293000.0, down 42.55% from the prior year.
  • Leases for Q1 2026 stood at $237000.0, down from $293000.0 in the prior quarter.
  • Across five years, Leases topped out at $1.0 million in Q1 2022 and bottomed at $237000.0 in Q1 2026.
  • The 5-year median for Leases is $664000.0 (2024), against an average of $653823.5.
  • The widest annual swing landed in 2022, when Leases soared 803.81%; it then tumbled 48.14% in 2026.
  • A 5-year view of Leases shows it stood at $903000.0 in 2022, then dropped by 21.04% to $713000.0 in 2023, then decreased by 28.47% to $510000.0 in 2024, then slumped by 42.55% to $293000.0 in 2025, then slipped by 19.11% to $237000.0 in 2026.
  • The last three Leases figures came in at $237000.0 (Q1 2026), $293000.0 (Q4 2025), and $349000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Leases (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 547.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 99.30 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 73.10 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 396.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 155.20 Mn
10 Nuwellis 1.45 Mn -630,292.49 1.68 Mn 237,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 237,000.00
Dec 31, 2025 293,000.00
Sep 30, 2025 349,000.00
Jun 30, 2025 404,000.00
Mar 31, 2025 457,000.00
Dec 31, 2024 510,000.00
Sep 30, 2024 563,000.00
Jun 30, 2024 613,000.00
Mar 31, 2024 664,000.00
Dec 31, 2023 713,000.00
Sep 30, 2023 762,000.00
Jun 30, 2023 810,000.00
Mar 31, 2023 856,000.00
Dec 31, 2022 903,000.00
Sep 30, 2022 949,000.00
Jun 30, 2022 994,000.00
Mar 31, 2022 1.04 Mn
Dec 31, 2021 1.08 Mn
Sep 30, 2021 105,000.00
Jun 30, 2021 156,000.00
Mar 31, 2021 206,000.00
Dec 31, 2020 255,000.00
Sep 30, 2020 303,000.00
Jun 30, 2020 351,000.00
Mar 31, 2020 397,000.00
Dec 31, 2019 442,000.00
Sep 30, 2019 487,000.00
Jun 30, 2019 531,000.00
Mar 31, 2019 574,000.00